TY - CHAP M1 - Book, Section TI - Antituberculous Medications A1 - Gruenberg, Katherine A1 - Guglielmo, B. Joseph A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. Y1 - 2022 N1 - T2 - Current Medical Diagnosis & Treatment 2022 AB - Mycobacteria are intracellular, have long periods of metabolic inactivity, and tend to develop resistance to any one medication. Therefore, combined medication therapy is used to delay the emergence of resistance. First-line medications, increasingly used together in the treatment of tuberculosis, are isoniazid, ethambutol, rifampin, and pyrazinamide. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1184154203 ER -